移植患者纳入药物康复服务后依从性的改善

IF 0.6 Q4 HEALTH POLICY & SERVICES
Farmaceuticos Comunitarios Pub Date : 2025-02-09 eCollection Date: 2025-04-15 DOI:10.33620/FC.2173-9218.(2025).10
M E Sánchez-Calero, D Pérez-Sánchez
{"title":"移植患者纳入药物康复服务后依从性的改善","authors":"M E Sánchez-Calero, D Pérez-Sánchez","doi":"10.33620/FC.2173-9218.(2025).10","DOIUrl":null,"url":null,"abstract":"<p><p>Male patient, 75 years of age, pluripathological and polymedicated. He underwent a liver transplant in 2006 so he was followed up by two hospitals in different provinces (Madrid and Castilla-La Mancha) which made the review even more difficult. the last few months, the pharmacists have noticed various discrepancies when dispensing his electronic prescriptions. We decided to offer him the Monitored Dosage Systems (MDS). He is a vulnerable patient given his pathologies and meets all the requirements to include him in the program.In a first interview, the patient is confused with the medication, he brings us full boxes of some medications and others are missing, suspecting that he does not follow the dosage indicated by the doctor, with the consequent lack of adherence to treatment.After the medication review, we found different Drug-Related Problems (DRPs): duplicity and dosage, regimen and/or inadequate duration. We contacted the primary care physician (GP) and the gastroenterologist to review the prescribed medication.After 8 months of being included in the MDS service, there has been a positive impact on the patient. He's health has significantly improved; he has gained weight, decreased the number of medication and improved his therapeutic adherence.</p>","PeriodicalId":40648,"journal":{"name":"Farmaceuticos Comunitarios","volume":"17 2","pages":"15-20"},"PeriodicalIF":0.6000,"publicationDate":"2025-02-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12020983/pdf/","citationCount":"0","resultStr":"{\"title\":\"[Adherence Improvement in Transplant Patient after Being Included in Medication Reconditioning Service].\",\"authors\":\"M E Sánchez-Calero, D Pérez-Sánchez\",\"doi\":\"10.33620/FC.2173-9218.(2025).10\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Male patient, 75 years of age, pluripathological and polymedicated. He underwent a liver transplant in 2006 so he was followed up by two hospitals in different provinces (Madrid and Castilla-La Mancha) which made the review even more difficult. the last few months, the pharmacists have noticed various discrepancies when dispensing his electronic prescriptions. We decided to offer him the Monitored Dosage Systems (MDS). He is a vulnerable patient given his pathologies and meets all the requirements to include him in the program.In a first interview, the patient is confused with the medication, he brings us full boxes of some medications and others are missing, suspecting that he does not follow the dosage indicated by the doctor, with the consequent lack of adherence to treatment.After the medication review, we found different Drug-Related Problems (DRPs): duplicity and dosage, regimen and/or inadequate duration. We contacted the primary care physician (GP) and the gastroenterologist to review the prescribed medication.After 8 months of being included in the MDS service, there has been a positive impact on the patient. He's health has significantly improved; he has gained weight, decreased the number of medication and improved his therapeutic adherence.</p>\",\"PeriodicalId\":40648,\"journal\":{\"name\":\"Farmaceuticos Comunitarios\",\"volume\":\"17 2\",\"pages\":\"15-20\"},\"PeriodicalIF\":0.6000,\"publicationDate\":\"2025-02-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12020983/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Farmaceuticos Comunitarios\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.33620/FC.2173-9218.(2025).10\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/4/15 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q4\",\"JCRName\":\"HEALTH POLICY & SERVICES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Farmaceuticos Comunitarios","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33620/FC.2173-9218.(2025).10","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/4/15 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"HEALTH POLICY & SERVICES","Score":null,"Total":0}
引用次数: 0

摘要

男性患者,75岁,多种病理,多种药物治疗。他在2006年接受了肝脏移植手术,因此他在不同省份的两家医院(马德里和卡斯蒂利亚-拉曼查)接受了随访,这使得审查更加困难。过去几个月,药剂师在配发他的电子处方时发现了各种差异。我们决定给他提供监测剂量系统(MDS)。考虑到他的病理,他是一个脆弱的病人,他符合纳入这个项目的所有要求。在第一次面谈中,患者对药物感到困惑,他给我们带来了满满一箱的药物,而其他药物却不见了,怀疑他没有按照医生指示的剂量服用,因此没有坚持治疗。在用药回顾后,我们发现了不同的药物相关问题(DRPs):重复和剂量、治疗方案和/或持续时间不足。我们联系了初级保健医生(GP)和胃肠病学家,以审查处方药物。在加入MDS服务8个月后,对患者产生了积极的影响。他的健康状况有了明显改善;他的体重增加了,服药次数减少了,治疗依从性也提高了。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
[Adherence Improvement in Transplant Patient after Being Included in Medication Reconditioning Service].

Male patient, 75 years of age, pluripathological and polymedicated. He underwent a liver transplant in 2006 so he was followed up by two hospitals in different provinces (Madrid and Castilla-La Mancha) which made the review even more difficult. the last few months, the pharmacists have noticed various discrepancies when dispensing his electronic prescriptions. We decided to offer him the Monitored Dosage Systems (MDS). He is a vulnerable patient given his pathologies and meets all the requirements to include him in the program.In a first interview, the patient is confused with the medication, he brings us full boxes of some medications and others are missing, suspecting that he does not follow the dosage indicated by the doctor, with the consequent lack of adherence to treatment.After the medication review, we found different Drug-Related Problems (DRPs): duplicity and dosage, regimen and/or inadequate duration. We contacted the primary care physician (GP) and the gastroenterologist to review the prescribed medication.After 8 months of being included in the MDS service, there has been a positive impact on the patient. He's health has significantly improved; he has gained weight, decreased the number of medication and improved his therapeutic adherence.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Farmaceuticos Comunitarios
Farmaceuticos Comunitarios HEALTH POLICY & SERVICES-
CiteScore
0.40
自引率
33.30%
发文量
351
审稿时长
5 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信